Skip to Content

Advitech Announces Positive Preclinical Results for Wound-Healing Application

QUEBEC CITY, Quebec, Oct. 10, 2007 /CNW Telbec/ - Advitech Inc. ("Advitech" or the  "Corporation") (TSX Venture Exchange: AVI) today announced that two milk-derived protein extracts from its XP-828L technological platform have demonstrated wound-healing properties in an in vivo study conducted by Dr. Charles Doillon of the Oncology and Molecular Endocrinology Research Centre at  the Centre Hospitalier de l'Université Laval (CHUL). Dr. Doillon is a  recognized researcher in the field of wound healing and angiogenesis. The  study has demonstrated that both protein extracts could significantly impact  the wound-healing response, especially the formation of regenerated collagen  fibre and its remodelling in wound tissue.      

"The data further confirms the bio-activity of our protein extracts and  brings new opportunities for Advitech. The results suggest that these two  products act early in the healing process and would accelerate wound-healing  without excessive long-term remodelling", stated Dr. Christina Juneau,  Vice-President, Research and Development. "Three potential fields of  application have been identified", added Dr. Juneau:   

     1. The management of skin ulcers, particularly pressure ulcers;   

     2. The improvement of scar tissue response in plastic and reconstructive surgery and dermabrasion;   

     3. The acceleration of the healing process in burn wounds.   

"Part of our 2007 business plan focuses on the identification of new  commercial opportunities targeting dermatological applications, with  additional revenues for the 2008 fiscal year", stated Renaud Beauchesne,  president and CEO at Advitech. "With these positive results regarding  wound-healing applications, we have achieved an additional milestone in our  plan, while developing our natural growth factor based technological platform  with respect to natural growth factors", commented Mr. Beauchesne.      

According to Espicom Business Intelligence Ltd., the global wound care  market totalled $7.2 billion in 2006, with a 10% growth rate. Growth factor  based applications for wound-healing represent more than 5% of the market,  with an impressive 27% growth rate.   

Posted: October 2007